Alpha-interferon in the treatment of subacute sclerosing panencephalitis.
J Child Neurol
; 12(8): 486-8, 1997 Nov.
Article
em En
| MEDLINE
| ID: mdl-9430312
ABSTRACT
Subacute sclerosing panencephalitis is an inexorably progressive disease with no effective therapy. Recent trials of intrathecal and intraventricular alpha-interferon yielded controversial results. We tried intrathecal or intraventricular alpha-interferon in four patients with subacute sclerosing panencephalitis. None of them had evidence of improvement. We reviewed the previously published studies on the use of alpha-interferon in subacute sclerosing panencephalitis. Further international collaborative studies are needed to determine the role of alpha-interferon in the treatment of subacute sclerosing panencephalitis.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Panencefalite Esclerosante Subaguda
/
Interferon-alfa
Limite:
Adult
/
Child
/
Humans
/
Male
Idioma:
En
Ano de publicação:
1997
Tipo de documento:
Article